Search

Displaying results 9191 - 9200 of 10000 in total
  1. Drug

    Telbermin

    go.drugbank.com/drugs/DB12639
    Investigational

    Telbermin has been used in trials studying the treatment of Foot Ulcer, Foot Ulcer, Diabetic, and Amyotrophic Lateral Sclerosis.

  2. Drug

    Rabacfosadine

    go.drugbank.com/drugs/DB12762
    Investigational

    Rabacfosadine has been used in trials studying the treatment of Multiple Myeloma, Non-Hodgkin's Lymphoma, and Chronic Lymphocytic Leukemia.

  3. Drug

    Dichloroisoproterenol

    go.drugbank.com/drugs/DB12803
    Investigational

    Dichloroisoproterenol has been used in trials studying the treatment and basic science of Insulin Resistance and Polycystic Ovary Syndrome.

  4. Drug

    MaaT013

    go.drugbank.com/drugs/DB18648
    Investigational

    MaaT013 is an allogeneic fecal microbiota therapy. It is being investigated for the treatment of Graft-Versus-Host Disease.

  5. Drug

    Coprelotamab

    go.drugbank.com/drugs/DB16380
    Investigational

    Coprelotamab is under investigation in clinical trial NCT04170595 (Clinical Study of Recombinant Anti-her2 Humanized Monoclonal Antibody for Injection).

  6. Drug

    Toralizumab

    go.drugbank.com/drugs/DB16384
    Investigational

    Toralizumab is under investigation in clinical trial NCT03605927 (CD40-L Blockade for Prevention of Acute Graft-versus-host Disease).

  7. Drug

    Clesacostat

    go.drugbank.com/drugs/DB18956
    Investigational

    Clesacostat is under investigation in clinical trial NCT04321031 (Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)).

  8. Drug

    Dimepheptanol

    go.drugbank.com/drugs/DB19094
    Investigational

    Dimepheptanol is under investigation in clinical trial NCT00218127 (Treatment of Opioid/heroin Dependence: Comparison of Three Medication Dosing Regimens).

  9. Drug

    Dasiprotimut-T

    go.drugbank.com/drugs/DB17287
    Experimental

    [A254701] It has been investigated in clinical trials.

  10. Drug

    S64315

    go.drugbank.com/drugs/DB17559
    Investigational

    S64315 (MIK665) is an inhibitor of induced myeloid leukemia cell differentiation protein Myeloid cell leukemia 1 (Mcl-1).[A257311]